It is usual to stop prophylaxis of most surgical patients at hospital discharge. However, there is increasing evidence that some patients are at risk of thromboembolism after treatment is stopped. Some evidence and several proposals from the literature are presented, but to date, the situation remains unclear.
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The duration of therapy for the prevention of deep vein thrombosis (DVT) in patients undergoing surgery should depend on the length of time the patient is exposed to thromboembolic risk. Yet prophylaxis is usually stopped when the patient is discharged. A few investigators have questioned this seemingly illogical practice (1) (2) (3) (4) .
It has been known for quite some time that the incidence of pulmonary embolism (PE) occurring after preventive therapy is discontinued and discovered at autopsy may be as high as 20 to 50% of all cases of PE (5-7).
A similar rate was observed in general surgical patients by a team in Geneva (8) in subjects who were treated and discharged from the hospital with no apparent clinical signs of venous thrombosis. The mean time of onset of such a complication was postoperative day 18. In addition, a considerable number of cases of PE were observed in specialized surgical departments: neurosurgery (9), oncology (10) , and especially orthopedic surgery, in particular following hip replacement surgery. In almost 8,000 patients, nearly three-fourths of fatal PEs occurred after postoperative day 7 (11) . Many studies have confirmed the reality of such cases of lateonset PE (12) (13) (14) (15) (16) (17) (18) (19) , the earliest cases having been reported in the early 1960s (20) .
The same type of findings has been reported for cases of DVT occurring after patients were dis-charged from the hospital (2, 4) . The frequency of the latter may be as high as 67% of all cases of thrombotic complications as reported in the classical study by Scurr et al. (21) . Similar rates have been reported in orthopedic surgery (22) (23) (24) such that thromboembolism following hip replacement surgery is the most common cause of rehospitalization (25) .
And yet, there is no consensus opinion on optimum management of such patients. Some investigators even consider thromboembolic risk following general surgery or orthopedic surgery to be negligible (26) (27) (28) (29) (30) .
The reason for these differences should be sought in the methods of investigation used: some studies were retrospective trials, while others were prospective. Some studies were based simply on clinical observation of patients, while others used very sensitive methods of investigation (21) . The incidence of such complications differed by a factor of 1 to 10. Moreover, interpretation of PE is very difficult in these situations (31) . In such unclear situations, at least five points have to be questioned. The answers (if any) could facilitate making a few proposals. Question 1. Can it be confirmed that a patient being discharged from the hospital is free of venous thrombosis? The answer is obviously no, because no method reduces the incidence of thrombosis to zero. Many trials corroborate this fact (2, 8, 18, (32) (33) (34) .
For example, half of the patients who undergo knee replacement surgery develop DVT by postoperative day 7 (20% of whom have proximal DVT). If venography were not performed, practically all of them would be considered good responder to therapy since 97% are asymptomatic (35) . Question 2. Does &dquo;thromboembolic disease&dquo; stop when a patient is discharged from the hospital? It has long been recognized that there is a trend to development of hypercoagulability (36, 37) , with a peak occurring at about postoperative day 7, exemplified by an increasing need for heparin (38, 39) . For example, to maintain the activated partial thromboplastin time at between 31 and 36 s in patients who underwent hip replacement surgery, therapy of 10,500 IU of heparin daily was necessary on day 1, but 18,900 IU on day 7 (40) . Existing coagulation abnormalities such as resistance to activated protein C must also be taken into account (41) . Finally, the presence of prolonged venous stasis (42) (43) (44) (45) (46) and alterations in the venous wall following hip surgery, possible initial events in thrombogenesis, must also be considered (46) . Question 3. Could prophylactic therapy have delayed the development of DVT in such treated patients ? This delay has been reported previously both in general surgery (47) and in orthopedic surgery (22, 24, 48, 49) , regardless of the therapeutic regimen used (12, 24) . It has been interpreted as corresponding to a second peak period of thrombotic events occurring after postoperative day 7. Is this the manifestation of recurrence of risk factors momentarily neutralized by prophylactic therapy? Question 4. Do somc paticnts have a higher risk of DVT? An hypothesis can be formulated that risk factors that can be determined on day 0 many rating scales (50-52)] are not very different from those present on day 7. Unfortunately, the experience of the Geneva team (8) led to the paradoxical conclusion that the lower the theoretical risk of DVT on day 7, the higher the thromboembolic event rate subsequently.
Question 5. What is the outcome of patients with venous thrombosis who are asymptomatic when discharged from the hospital? A high proportion of the cases will remain stable, or will lyse spontaneously, and will definitely remain undetected. Other patients will sooner or later develop a thromboembolic complication unexpectedly (18) .
WHAT APPROACH SHOULD BE ADOPTED .
IN 1996?
As soon as a high-risk patient enters the hospital, prophylactic management should be planned. According to recent surveys (53, 54) , barely half of such patients receive prophylactic therapy. It is also necessary to treat these patients with the most effective regimen available, which is not always performed in practice (55) . Both of these measures aim to reduce the percentage of the total patients discharged with asymptomatic DVT. These measures have proven to be cost-effective (56) .
When a patient is to be discharged from the hospital, several questions should come to mind.
(a) Should prophylactic therapy be systematically continued after the patient is released? The answer obviously is no, and no such recommendation has been advocated (52) (53) (54) (55) (56) .
(b) Should objective investigations be used to determine that the patient is free of DVT? It is recognized that noninvasive methods of investigation are sufficiently sensitive to detect proximal venous thromboses (57,58) but not for distal vein thromboses, which, nevertheless, may induce embolic events (59, 60) . Venography has been shown to have limitations (61-63) and possible risks (64) . In any event, it is not feasible to generalize such investigations, as they are both complicated to perform and costly, and their usefulness has not been demonstrated beyond doubt.
(c) Should prophylactic therapy be continued in some surgical patients? There seems to be little doubt that patients who undergo orthopedic surgery are good candidates for such therapy (14, 17, 19, 34) . In addition, when a patient presents individual risk factors that persist after discharge (50) , regardless of the type of surgery performed, continuation of therapy can be proposed (65) , specifically in patients for whom postoperative mobilization is difficult or impossible (66) .
(d) What is the optimum duration for extension of preventive therapy? Since no precise data are available, no consensus conference has made any specific recommendations. Periods of therapy of 3 to 6 weeks have been proposed in orthopedic patients, taking physical activity into account (2, 34) . But the cost/benefit ratio has not been evaluated.
(e) What type of prophylactic therapy should be used? Here, too, there is no consensus. Two types of management can be distinguished. If planned therapy is to be of a short duration, the simplest strategy would be to continue initial therapy, taking the usual conventional precautions. If, on the contrary, more prolonged therapy is planned, it would appear logical to use oral anticoagulant drugs timed so that after a 3or 4-day period of overlapping action, the patient's condition would be controlled (INR = 1.5 to 2.5).
The value of graduated elastic compression stockings, and more generally the role of active mobilization, should be emphasized (2, 67) . (68) , &dquo;In the light of current knowledge, selection of patients to be treated should be based on clinical findings,&dquo; with Bergqvist's (29) disillusioned response, &dquo;As long as we do not have scientifically established evidence, we must rely on intuition in 1991.&dquo;
A recent comment by Kakkar (26) should also be kept in mind: &dquo;Is it wise to extend prophylactic therapy to all my 3,358 patients who underwent abdominal surgery to prevent the death of 3 seriously or critically-ill ones from PE?&dquo; Nevertheless, no patient at risk for venous thromboembolism should be left unprotected (69) , taking into account the risks inherent in anticoagulant treatment (26) . Since to date no consensus exists, it is important to continue these investigations, as shown by the many related studies presented at the recent XV ISTH meeting in Jerusalem (1995) .
Ages ago, as stated in the Bible, God created his entire undertaking within 6 days and rested on the seventh day. Today, physicians must still rely on intuition to decide in which patients their job is not complete by day 6. 
